Skip to content

Interest of a Nursing Consultation in the Empowerment of the Patient With Rheumatoid Arthritis in the Management of His Subcutaneous Biotherapy

Interest of a Nursing Consultation in the Empowerment of the Patient With Rheumatoid Arthritis in the Management of His Subcutaneous Biotherapy

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05762185
Acronym
PRECI
Enrollment
71
Registered
2023-03-09
Start date
2019-11-06
Completion date
2024-02-13
Last updated
2026-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biotherapies, Rheumatoid Arthritis, Rheumatology

Keywords

nurse consultation, biotherapies, Rheumatology, Rheumatoid Arthritis

Brief summary

Biotherapy present specifics risks that patients must know and learn to manage. A national survey has been carried in this study to evaluate patients safety skills. (wording: " cross study of safety skills of 677 patients treat by biopharmaceuticals for an inflammatory rheumatism). This survey has allowed showcasing patients difficulties in managing their treatment, including for those under subcutaneous biotherapy. More than 60% patients interviewed doesn't know symptoms to bring them to consult and mainly postpone to their injection. The aim of this study is to prove that nursing consultation can allow the patient to become independent in treatment management and thus avoid occurrence of adverse event.

Interventions

nursing consultation

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient suffering from rheumatoid arthritis followed by Rheumatology consultation of Amiens-Picardie University Hospital * Patient treated by Subcutaneous Biotherapy for at least 6 months at the time of inclusion * Major patient * Patient having signed an informed consent

Exclusion criteria

* Minor patient * Patient with cognitive impairment diagnosed by a physician * Patient under tutorship or curatorship * Patient deaf or hard of hearing * Patient not fluent in the French language (at the decision of the investigator)

Design outcomes

Primary

MeasureTime frameDescription
Variation of BIOSECURE score between baseline and after nurse consultationone dayBiosecure questionnaire is assessing patient theoretical and practical understanding of biotherapy. Highest score is 100.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 13, 2026